We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+12.3%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$51B
AUM Growth
+$15.4B
Cap. Flow
+$11.4B
Cap. Flow %
22.45%
Top 10 Hldgs %
32.55%
Holding
2,383
New
382
Increased
1,739
Reduced
215
Closed
45

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$973M
2
MSFT icon
Microsoft
MSFT
+$944M
3
META icon
Meta Platforms (Facebook)
META
+$686M
4
AMZN icon
Amazon
AMZN
+$561M
5
NVDA icon
NVIDIA
NVDA
+$341M

Top Sells

Rank Stock Value
1
LEG icon
Leggett & Platt
LEG
+$127M
2
PBCT
People's United Financial Inc
PBCT
+$25.8M
3
ALB icon
Albemarle
ALB
+$25.2M
4
CDW icon
CDW
CDW
+$25.2M
5
FDS icon
Factset
FDS
+$23.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Consumer Discretionary 13.39%
3 Communication Services 11.47%
4 Healthcare 9.06%
5 Consumer Staples 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERU icon
2226
Veru
VERU
$36.1M
$82K ﹤0.01%
+1,407
New +$108K
VTGN icon
2227
VistaGen Therapeutics
VTGN
$9.29M
$82K ﹤0.01%
1,413
+586
+71% +$38.1K
SPPI
2228
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$81K ﹤0.01%
63,845
+3,669
+6% +$6.56K
CTOS icon
2229
Custom Truck One Source
CTOS
$2.47B
$80K ﹤0.01%
+10,096
New +$87K
PRQR icon
2230
ProQR Therapeutics
PRQR
$243M
$80K ﹤0.01%
+10,020
New +$76.3K
PRTK
2231
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$80K ﹤0.01%
17,758
+1,234
+7% +$5.85K
RES icon
2232
RPC Inc
RES
$1.24B
$77K ﹤0.01%
16,992
+6,499
+62% +$31.9K
VLDR
2233
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$77K ﹤0.01%
+16,511
New +$96.5K
TTI icon
2234
TETRA Technologies
TTI
$1.23B
$76K ﹤0.01%
26,814
+11,088
+71% +$34.2K
ALTO icon
2235
Alto Ingredients
ALTO
$360M
$75K ﹤0.01%
+15,593
New +$81.8K
BNED icon
2236
Barnes & Noble Education
BNED
$412M
$75K ﹤0.01%
+110
New +$101K
OIS icon
2237
Oil States International
OIS
$522M
$75K ﹤0.01%
+15,177
New +$89.3K
SYRE icon
2238
Spyre Therapeutics
SYRE
$8.87B
$75K ﹤0.01%
631
+5
+0.8% +$789
ADAP
2239
DELISTED
Adaptimmune Therapeutics
ADAP
$72K ﹤0.01%
19,315
-9,958
-34% -$45.3K
AKTS
2240
DELISTED
Akoustis Technologies Inc
AKTS
$71K ﹤0.01%
+10,679
New +$79.7K
INFI
2241
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$71K ﹤0.01%
31,661
+20,445
+182% +$51.3K
QMCO icon
2242
Quantum Corp
QMCO
$437M
$70K ﹤0.01%
+639
New +$72.8K
TRUE
2243
DELISTED
TrueCar
TRUE
$70K ﹤0.01%
20,824
+8,606
+70% +$32.7K
KOPN icon
2244
Kopin
KOPN
$663M
$69K ﹤0.01%
+16,954
New +$86.1K
VKTX icon
2245
Viking Therapeutics
VKTX
$4.04B
$69K ﹤0.01%
+14,947
New +$83.8K
SYRS
2246
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$69K ﹤0.01%
2,130
+69
+3% +$2.79K
SURF
2247
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$68K ﹤0.01%
14,216
+45
+0.3% +$290
DNTH icon
2248
Dianthus Therapeutics
DNTH
$5.68B
$67K ﹤0.01%
926
-96
-9% -$9.65K
LCTX icon
2249
Lineage Cell Therapeutics
LCTX
$257M
$67K ﹤0.01%
27,397
+11,326
+70% +$26.5K
NGNE icon
2250
Neurogene
NGNE
$696M
$67K ﹤0.01%
683
+4
+0.6% +$487

Similar funds

ProShare Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, ProShare Advisors held 2,383 positions worth $51B, up 43% from $35.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

ProShare Advisors deployed $11.4B of net new capital in Q4 2021, opening 382 new positions and adding to 1,739 existing holdings. Its largest new stake was Lucid Motors: 272,628 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Leggett & Platt, an estimated $127M trimmed.

  • ProShare Advisors's largest Q4 2021 buy was Lucid Motors: 272,628 shares worth $104M.
  • ProShare Advisors added most to Apple in Q4 2021, an estimated $973M increase.
  • ProShare Advisors's biggest Q4 2021 reduction was Leggett & Platt, cutting an estimated $127M.
  • ProShare Advisors fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $20.9M.
  • ProShare Advisors's ten largest holdings make up 33% of its $51B portfolio in Q4 2021.
  • ProShare Advisors opened 382 new positions and closed 45 in Q4 2021.
  • ProShare Advisors's portfolio value rose 43% quarter-over-quarter to $51B.

Based on ProShare Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.